# South Carolina Senate Passes THC Restrictions to Protect Teens > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/south-carolina-thc-restrictions-cannabis-products/ > **Published:** 2026-03-25T21:33:50-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:21-04:00 > **Clinical Summary:** Explore South Carolina THC restrictions aimed at limiting cannabis product potency to reduce adolescent access and protect youth health. --- ✦ New CED Clinical Relevance #55 [Clinical Context](https://cedclinic.com/cannabis-hyperemesis-syndrome-treatment-insights-2026/) Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyTHCSafetyPediatrics Clinical Summary # Clinical Summary South Carolina’s Senate has passed legislation implementing THC content restrictions on cannabis products, primarily motivated by concerns about adolescent access and use. These regulatory changes establish legal caps on tetrahydrocannabinol concentration in commercially available products, similar to restrictions adopted in other states. For clinicians, such regulations affect the pharmacological profile and dosing considerations of cannabis products available to adult patients, potentially limiting access to higher-potency formulations that some patients may benefit from therapeutically. The restriction framework also reflects ongoing tension between [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) efforts to reduce youth cannabis initiation and the clinical needs of adult patients requiring effective symptom management. Understanding these evolving state-level restrictions is important for clinicians counseling patients about product availability and discussing evidence-based [cannabis dosing](https://cedclinic.com/medical-cannabis-safety-facts/) within their local regulatory context. Clinicians should remain informed about their state’s THC restrictions and communicate transparently with patients about how regulatory limits may influence treatment options for their conditions. Dr. Caplan’s Take “What South Carolina is attempting with THC potency caps is clinically sound in principle, but we need to be honest that restriction without regulation actually pushes patients and teenagers toward uncontrolled black market products that are far more dangerous than anything a licensed dispensary would sell.” Clinical Perspective South Carolina’s proposed THC restrictions targeting youth access represent a reasonable public health response to growing concerns about potency and developmental exposure, though their clinical effectiveness remains uncertain given the widespread availability of products across state lines and online markets that such legislation cannot easily constrain. Clinicians should recognize that regulatory approaches addressing THC concentration and product availability are necessary but likely insufficient on their own, as they do not address underlying drivers of adolescent use such as peer influence, mental health conditions, or perceived risk, which remain important targets for preventive counseling. The evidence that higher-potency products pose greater risks to developing brains is accumulating but still evolving, and variation in individual susceptibility means restrictions alone will not eliminate harm for all users. Healthcare providers should view such legislation as one component of a broader prevention strategy and continue screening adolescent patients for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) while providing evidence-based counseling about neurodevelopmental risks, particularly for those with family histories of psych 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+South+Carolina+Senate+passes+THC+restrictions+aimed+at+keeping+products+from+teens+%40drcaplan&url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dnk5jfZPl5qU)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dnk5jfZPl5qU)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+South+Carolina+Senate+passes+THC+restrictions+aimed+at+keeping+products+from+teens+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3Dnk5jfZPl5qU)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - Bill regulating THC drinks and gummies clears key hurdle in South Carolina Senate - [CED Digest: 230 Items — March 18, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) - [CED Digest: 239 Items — March 17, 2026](https://cedclinic.com/cannabis-clinical-digest-march-17-2026/) 📰 Source: [https://www.youtube.com/watch?v=nk5jfZPl5qU](https://www.youtube.com/watch?v=nk5jfZPl5qU) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Bill regulating THC edible sales in SC nears Gov. McMaster's desk – WPDE](https://cedclinic.com/south-carolina-thc-edible-regulation/) Details on South Carolina's legislative efforts to regulate THC edibles and protect youth from high-potency cannabis products. [Read More](https://cedclinic.com/south-carolina-thc-edible-regulation/) [THC-infused drinks face new restrictions – Columbus – NBC4](https://cedclinic.com/thc-infused-beverages-restrictions-ohio/) An overview of new restrictions on THC-infused drinks highlighting regulatory trends similar to South Carolina's approach. [Learn More](https://cedclinic.com/thc-infused-beverages-restrictions-ohio/) [Oregon bill to limit how much THC goes into each edible fails](https://cedclinic.com/oregons-cannabis-edible-regulation-thc-limits-fail/) Insights into challenges faced by states like Oregon in implementing THC limits, providing context for South Carolina's legislation. [Explore Details](https://cedclinic.com/oregons-cannabis-edible-regulation-thc-limits-fail/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).